114 related articles for article (PubMed ID: 10619186)
21. Inhibitory effects of indomethacin on growth and proliferation of gastric carcinoma cells KATO III.
Fujiwara Y; Tarnawski A; Fujiwara K; Arakawa T; Kobayashi K
J Physiol Pharmacol; 1993 Jun; 44(2):147-53. PubMed ID: 8358051
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human telomerase in MKN-45 cell line by antisense hTR expression vector induces cell apoptosis and growth arrest.
Feng RH; Zhu ZG; Li JF; Liu BY; Yan M; Yin HR; Lin YZ
World J Gastroenterol; 2002 Jun; 8(3):436-40. PubMed ID: 12046065
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
24. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
Yeh CW; Huang SS; Lee RP; Yung BY
Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
[TBL] [Abstract][Full Text] [Related]
25. Indomethacin and telomerase activity in tumor growth retardation.
Lönnroth C; Andersson M; Lundholm K
Int J Oncol; 2001 May; 18(5):929-37. PubMed ID: 11295037
[TBL] [Abstract][Full Text] [Related]
26. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells.
Yung BY
FEBS Lett; 2004 Dec; 578(3):211-6. PubMed ID: 15589822
[TBL] [Abstract][Full Text] [Related]
27. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of human telomerase antisense oligodeoxyribonucleotides on the growth of gastric cancer cell lines in variant tumor pathological subtype.
Ye J; Wu YL; Zhang S; Chen Z; Guo LX; Zhou RY; Xie H
World J Gastroenterol; 2005 Apr; 11(15):2230-7. PubMed ID: 15818731
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.
Subong EN; Shue MJ; Epstein JI; Briggman JV; Chan PK; Partin AW
Prostate; 1999 Jun; 39(4):298-304. PubMed ID: 10344220
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the nucleolar protein nucleophosmin/B23 in collagen lattice-cultured fibroblasts: potential role in the control of protein synthesis.
Lefèvre F; Garnotel R; Georges N; Gillery P
Mol Cell Biochem; 2002 Jan; 229(1-2):45-50. PubMed ID: 11936846
[TBL] [Abstract][Full Text] [Related]
31. Telomere length and telomerase activity in carcinogenesis of the stomach.
Maruyama Y; Hanai H; Fujita M; Kaneko E
Jpn J Clin Oncol; 1997 Aug; 27(4):216-20. PubMed ID: 9379506
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach.
Yasui W; Tahara E; Tahara H; Fujimoto J; Naka K; Nakayama J; Ishikawa F; Ide T; Tahara E
Jpn J Cancer Res; 1999 Jun; 90(6):589-95. PubMed ID: 10429648
[TBL] [Abstract][Full Text] [Related]
33. Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer.
Zhou F; Chen E; You D; Song Y; Sun Z; Yue L
APMIS; 2016 Dec; 124(12):1046-1053. PubMed ID: 27714846
[TBL] [Abstract][Full Text] [Related]
34. [Changes of alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis].
Xu JH; Wang YC; Geng X; Zhang WM
Ai Zheng; 2008 Dec; 27(12):1271-6. PubMed ID: 19079992
[TBL] [Abstract][Full Text] [Related]
35. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Fu XH; Zhang JS; Zhang N; Zhang YD
World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
[TBL] [Abstract][Full Text] [Related]
36. Indomethacin interferes with epidermal growth factor binding and proliferative response of gastric KATO III cells.
Fujiwara Y; Schmassmann A; Arakawa T; Halter F; Tarnawski A
Digestion; 1995; 56(5):364-9. PubMed ID: 8549878
[TBL] [Abstract][Full Text] [Related]
37. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
39. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Zhou JH; Zhang HM; Chen Q; Han DD; Pei F; Zhang LS; Yang DT
World J Gastroenterol; 2003 Aug; 9(8):1808-14. PubMed ID: 12918126
[TBL] [Abstract][Full Text] [Related]
40. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]